The Medicines and Healthcare products Regulatory Agency has told healthcare professionals to immediately stop supplying batches of Epilim 500mg gastro-resistant tablets.

The medicines regular’s instruction follows a recall of the product by manufacturer Sanofi due to what the PSNC reported was “out of specification results for disintegration test during routine stability testing.”

The MHRA also said affected stock with the batch numbers R0601, R0602 and R0603 should be quarantined and returned to suppliers.